SCHEMBL2680939

SCHEMBL2680939

CCC(=O)c1c(C2CNCC3C(=O)NC(=O)N32)nc2c(-c3cnc4ccccc4c3)cnn2c1N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 5/20 0.37
MTOR P42345 4/20 0.36
AKT1 P31749 2/20 0.36
BRD4 O60885 2/20 0.34
CREBBP Q92793 2/20 0.34
AXL P30530 1/20 0.33
MERTK Q12866 1/20 0.33
CHEK1 O14757 3/20 0.33
CCNA2 P20248 3/20 0.33
CDK2 P24941 3/20 0.33
CCNA1 P78396 3/20 0.33
FASN P49327 2/20 0.33
HSP90AA1 P07900 1/20 0.33
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2680938 0.79 PIK3CA (0.35) PIK3CAMTORAKT1BRD4CREBBP
SCHEMBL598855 0.75 BRD4 (0.32) PIK3CABRD4CREBBP
SCHEMBL2680940 0.73 PIK3CA (0.36) PIK3CAMTORAKT1BRD4CREBBP
SCHEMBL2686645 0.73 PIK3CA (0.36) PIK3CAMTORAKT1FASNHSP90AA1
SCHEMBL7885236 0.72 PIK3CA (0.36) PIK3CAMTORAKT1BRD4CREBBP
SCHEMBL7875031 0.71 PIK3CA (0.41) PIK3CAMTORAKT1CHEK1CCNA2
SCHEMBL7878718 0.71 PIK3CA (0.41) PIK3CAMTORAKT1CHEK1CCNA2
SCHEMBL10280112 0.70 PIK3CA (0.35) PIK3CAMTORAKT1BRD4CREBBP
SCHEMBL10236611 0.70 CHEK1 (0.42) PIK3CAMTORAKT1BRD4CREBBP
SCHEMBL6894334 0.70 CHEK1 (0.42) PIK3CAMTORAKT1BRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8591943-B2 Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors MERCK SHARP & DOHME CORP. (US) 2013-11-26 US disclosed
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MERCK SHARP & DOHME LLC 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120114739-A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MTOR, RICTOR, RPTOR PIK3CA 34/4885MTOR 1/4885AKT1 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.